Alerts will be sent to your verified email
Verify Email
TRABI
|
Transgene Biotek
|
KK Shah Hospitals
|
Nidan Labs. & Health
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
-39.86 % | 2.05 % | 4.89 % |
|
5yr average Equity Multiplier
|
9.29 | 1.1 | 1.8 |
|
5yr Average Asset Turnover Ratio
|
0.0 | 0.47 | 0.32 |
|
5yr Avg Net Profit Margin
|
-67187.68 % | 5.16 % | 5.91 % |
|
Price to Book
|
2.89 | 2.31 | 0.4 |
|
P/E
|
0.0 | 0.0 | 13.43 |
|
5yr Avg Cash Conversion Cycle
|
65.65 Days | 3.41 Days | -378.19 Days |
|
Inventory Days
|
866.48 Days | 0.0 | 3.89 Days |
|
Days Receivable
|
13.05 Days | 3.41 Days | 13.34 Days |
|
Days Payable
|
1913.74 Days | 0.0 | 205.76 Days |
|
5yr Average Interest Coverage Ratio
|
-24.4 | -202.71 | 2.0 |
|
5yr Avg ROCE
|
-5.18 % | 2.76 % | 11.91 % |
|
5yr Avg Operating Profit Margin
|
-5270.55 % | 9.16 % | 30.14 % |
|
5 yr average Debt to Equity
|
0.8 | 0.0 | 0.73 |
|
5yr CAGR Net Profit
|
-42.99 % | n/a | -2.95 % |
|
5yr Average Return on Assets
|
-4.99 % | 2.0 % | 2.0 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
23.64 % | 71.36 % | 57.04 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.0 | -14.18 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Transgene Biotek
|
KK Shah Hospitals
|
Nidan Labs. & Health
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|